Opposing functions of gut immunomodulatory metabolites on CAR-T therapy
Cell · 2026-10 · 189 (22) · 6968-6987.e14
DOI: 10.1016/j.cell.2026.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026-10. Verfasst von Markus Perl und 56 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany; Bavarian Cancer Research Ce…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, German Cancer Aid.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)-T cell therapy has transformed hematological cancer treatment, yet nearly half of patients still relapse or progress. Increasing evidence implicates the gut microbiome and antibiotic exposure as key modulators of clinical outcomes. In a cohort of 129 patients across three German centers, shotgun metagenomics and targeted mass spectrometry revealed that reduced short-chain fatty acids, particularly valeric acid, prior to CAR-T cell therapy correlated with increased risk of disease progression. Conversely, high levels of indole metabolites, including indole-3-carboxaldehyde and indole-3-acetic acid as well as the branched-chain fatty acid isovaleric acid, were linked to adverse outcomes. Functional validation in human and murine CAR-T cell models demonstrated that valeric acid supplementation enhanced, while indole-3-carboxaldehyde and isovaleric acid impaired, CAR-T cell efficacy. These findings reveal the opposing roles of immunomodulatory metabolites on CAR-T cell therapy, carrying significant implications for the design of metabolite-guided, microbiome-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany; Bavarian Cancer Research Center (BZKF), Regensburg, Germany. Electronic address: markus.perl.ukr@…
- Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.
- Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.
- Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilian University (LMU) of Munich, Munich, Germany.
- Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- German Cancer Aid
Zitieren
APA
Perl, M., Guetter, S., Shah, D., Holzinger, S., Becker, L., Tariq, M., Menauer, P., Delahais, S., Lutzny-Geier, G., Scherer, J. N., Göttert, S., Herfeld, K., Heinrich, P., Kreitmeier, K. G., Gebhard, C., Herr, W., Trefny, M. P., Doerr, J., Sameri, S., …, & Poeck, H. (2026). Opposing functions of gut immunomodulatory metabolites on CAR-T therapy. Cell, 189(22), 6968-6987.e14. https://doi.org/10.1016/j.cell.2026.09.004
Vancouver
Perl M, Guetter S, Shah D, Holzinger S, Becker L, Tariq M, et al. Opposing functions of gut immunomodulatory metabolites on CAR-T therapy. Cell. 2026;189(22):6968-6987.e14. doi:10.1016/j.cell.2026.09.004
BibTeX
@article{Perl2026,
author = {Perl, Markus and Guetter, Severin and Shah, Dhyani and Holzinger, Simon and Becker, Luisa and Tariq, Misbah and Menauer, Philipp and Delahais, Simon and Lutzny-Geier, Gloria and Scherer, Julian N and Göttert, Sascha and Herfeld, Konstantin and Heinrich, Paul and Kreitmeier, Klaus Georg and Gebhard, Claudia and Herr, Wolfgang and Trefny, Marcel P and Doerr, Janina and Sameri, Saba and Harrer, Dennis C and Ziegler-Martin, Kai and Staudt, Sarah and Hansmann, Leo and Edinger, Matthias and Wolff, Daniel and Weber, Daniela and Meedt, Elisabeth and Denk, Alexander and Gessner, Andre and Holler, Ernst and Wertheimer, Tobias and Neuhaus, Klaus and Zheng, Tingting and Cordas Dos Santos, David M and Theurich, Sebastian and Schirmer, Melanie and Kleigrewe, Karin and Schluter, Jonas and van den Brink, Marcel and Schmitt, Michael and Feuerer, Markus and Heuser-Loy, Christoph and Baldwin, Jeremy and Gattinoni, Luca and Rehli, Michael and Hudecek, Michael and Bigenwald, Camille and Zitvogel, Laurence and Subklewe, Marion and Blumenberg, Viktoria and Schubert, Maria-Luisa and Stein-Thoeringer, Christoph and Luu, Maik and Kobold, Sebastian and Fante, Matthias A and Thiele Orberg, Erik and Poeck, Hendrik},
title = {Opposing functions of gut immunomodulatory metabolites on CAR-T therapy},
journal = {Cell},
year = {2026},
volume = {189},
number = {22},
pages = {6968--6987.e14},
doi = {10.1016/j.cell.2026.09.004}
}
EUVIMED